Potent Activity of Captive-Bred Bitis rhinoceros Venom Against Planktonic Clinical MRSA and Early Biofilm Development
Ontology highlight
ABSTRACT: Background: Antimicrobial resistance (AMR) represents a major global health threat, par-ticularly due to the increasing prevalence of multidrug-resistant pathogens such as methi-cillin-resistant Staphylococcus aureus (MRSA). Snake venoms have emerged as promising sources of bioactive molecules with potential antimicrobial applications. However, their activity against clinical MRSA isolates and bacterial biofilms remains insufficiently char-acterized. This study evaluated the antibacterial, biofilm formation inhibitory, and hemo-compatibility properties of venom obtained from a captive-bred Bitis rhinoceros specimen against S. aureus strains and clinical MRSA isolates. Methods: Minimum inhibitory con-centration (MIC), minimum bactericidal concentration (MBC), minimum biofilm inhibitory concentration (MBIC), minimum biofilm eradication concentration (MBEC), and biofilm formation inhibition assays were performed. In addition, direct and indirect haemolytic and hemagglutinating activities were evaluated to assess venom selectivity and biocom-patibility. Results: Bitis rhinoceros venom exhibited potent bactericidal activity against planktonic S. aureus cells, with MIC and MBC values ranging from 4 to 16 mg/L. Notably, clinical MRSA isolates exhibited greater susceptibility to the venom than the ATCC reference strain. The venom also strongly inhibited biofilm formation at the concentrations tested (p < 0.001), although limited activity was observed against preformed mature bio-films. Hemocompatibility assays demonstrated low direct and indirect hemolytic activity together with favorable selectivity indices against bacterial cells. Conclusion: These find-ings identify captive-bred B. rhinoceros venom as a promising source of antimicrobial compounds against planktonic MRSA infections and early-stage biofilm development. The favorable hemocompatibility profile supports its potential applicability as a topical anti-microbial candidate. Further studies are required to characterize the active venom frac-tions, evaluate cytotoxicity in additional mammalian cell models, and optimize strategies targeting mature biofilms.
INSTRUMENT(S):
ORGANISM(S): Bitis Rhinoceros
TISSUE(S): Venom
SUBMITTER:
Jordi Tena-Garces
LAB HEAD: Juan José Calvete Chornet
PROVIDER: PXD080981 | Pride | 2026-11-02
REPOSITORIES: Pride
ACCESS DATA